1. Home
  2. JG vs XLO Comparison

JG vs XLO Comparison

Compare JG & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Mobile Limited

JG

Aurora Mobile Limited

N/A

Current Price

$6.70

Market Cap

39.4M

Sector

Technology

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$0.70

Market Cap

41.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
JG
XLO
Founded
2012
2016
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
39.4M
41.8M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
JG
XLO
Price
$6.70
$0.70
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$2.00
AVG Volume (30 Days)
5.1K
492.2K
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$50,967,244.00
$31,804,000.00
Revenue This Year
$10.90
$626.78
Revenue Next Year
N/A
$79.08
P/E Ratio
N/A
N/A
Revenue Growth
20.78
588.40
52 Week Low
$5.75
$0.62
52 Week High
$20.94
$1.70

Technical Indicators

Market Signals
Indicator
JG
XLO
Relative Strength Index (RSI) 52.23 53.18
Support Level $6.16 $0.63
Resistance Level $6.59 $0.68
Average True Range (ATR) 0.29 0.03
MACD 0.02 0.01
Stochastic Oscillator 78.91 81.30

Price Performance

Historical Comparison
JG
XLO

About JG Aurora Mobile Limited

Aurora Mobile Ltd provides stable, and accurate developer services for educational and medical products. It is focused on providing companies with stable and efficient push notification services. It provides a comprehensive suite of services to mobile app developers in mainland China. Through its developer services, it gains access to, aggregate, cleanse, structure and encrypt vast amounts of real-time and anonymous device-level mobile behavioral data. It offers data services such as iAPP which helps the investors to analyze opportunities in the sector, Anti-fraud helps to identify fraud risks, iAudience, iZone and other related services. The company operates and generates its revenue from the People's Republic of China.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies and immune cell engagers.

Share on Social Networks: